<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>NHERF1 (<z:chebi fb="1" ids="29101">Na+</z:chebi>/H+ exchanger regulatory factorÂ 1) is expressed in the <z:chebi fb="2" ids="8069">luminal</z:chebi> membrane of many epithelia, and associated with proteins involved in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Alterations of NHERF1 expression in different sites of <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> (mCRC) suggest a dynamic role of this protein in colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We focused on the observation of the altered expression of NHERF1 from non-neoplastic tissues to metastatic sites by immunohistochemistry </plain></SENT>
<SENT sid="3" pm="."><plain>Moreover, we studied, by immunofluorescence, the colocalization between NHERF1 and the epidermal growth factor receptor (EGFR), whose overexpression is implicated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> progression </plain></SENT>
<SENT sid="4" pm="."><plain>NHERF1 showed a different localization and expression in the examined sites </plain></SENT>
<SENT sid="5" pm="."><plain>The distant non-neoplastic tissues showed NHERF1 mostly expressed at the apical membrane, while in surrounding non-neoplastic tissue decreased the apical membrane and increased cytoplasmic immunoreactivity </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:mpath ids='MPATH_270'>adenomas</z:mpath> a shift from apical membrane to cytoplasmic localization and nuclear expression were observed </plain></SENT>
<SENT sid="7" pm="."><plain>Cytoplasmic staining in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, and metastatic sites was stronger than surrounding non-neoplastic tissue </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, nuclear NHERF1 expression was noted in 80% of <z:hpo ids='HP_0000001'>all</z:hpo> samples and surprisingly, it appeared already in <z:mpath ids='MPATH_270'>adenoma</z:mpath> lesions, suggesting that NHERF1 represents an early marker of pre-morphological triggering of colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Then, in few <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> a positive direct correlation between membrane NHERF1 and EGFR expression was evidenced by their colocalization </plain></SENT>
<SENT sid="10" pm="."><plain>Nuclear NHERF1 expression, present in the early stages of <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and related with poor prognosis, may contribute to the <z:hpo ids='HP_0003674'>onset</z:hpo> of malignant phenotype </plain></SENT>
<SENT sid="11" pm="."><plain>Specifically, we hypothesize the direct involvement of nuclear NHERF1 in both <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and progression and its role as a potential <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> marker </plain></SENT>
</text></document>